BioCorRx (BICX) Treasury Shares (2013 - 2026)

BioCorRx has disclosed Treasury Shares across 14 years of filings, most recently posting $4.8 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $4.8 million, up 156.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (up 156.77% YoY), and the FY2025 annual result was $5.1 million, up 379.35% from the prior year.
• Treasury Shares came in at $4.8 million for Q1 2026 at BioCorRx, down from $5.1 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.1 million in Q4 2025 to a low of $320000.0 in Q3 2025.
• The 5-year median for Treasury Shares is $850856.0 (2023), against an average of $1.4 million.
• Across the five-year window, Treasury Shares sank 63.07% in 2024 and surged 379.35% in 2025, its largest moves.
• BioCorRx's Treasury Shares stood at $444167.0 in 2022, then jumped by 297.57% to $1.8 million in 2023, then slumped by 39.35% to $1.1 million in 2024, then surged by 379.35% to $5.1 million in 2025, then fell by 6.67% to $4.8 million in 2026.
• The last three Treasury Shares figures came in at $4.8 million (Q1 2026), $5.1 million (Q4 2025), and $320000.0 (Q3 2025), per Business Quant data.